# Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia Chronic Phase With Sustained MR4log

> **NCT03239886** · NA · UNKNOWN · sponsor: **University of Sao Paulo General Hospital** · enrollment: 30 (actual)

## Conditions studied

- Leukemia, Myeloid, Chronic-Phase

## Interventions

- **OTHER:** imatinib discontinuation

## Key facts

- **NCT ID:** NCT03239886
- **Lead sponsor:** University of Sao Paulo General Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2016-12-15
- **Primary completion:** 2019-08-31
- **Final completion:** 2020-01-31
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-03-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03239886

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03239886, "Imatinib Discontinuation in Patients With Chronic Myeloid Leukemia Chronic Phase With Sustained MR4log". Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/clinical/NCT03239886. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*